Bionpharma
Princeton, US · Founded 2014 · Delaware corporation · 1 known investors
Bionpharma researches, develops, and manufactures generic prescription drugs and over-the-counter products, and is one of the largest US suppliers of softgel capsules. It also sells OTC products online through its A+ Health brand on Amazon.
Founders & leadership
GM
Gaurav MehrotrainExecutiveGaurav Mehrotra brings over 25 years of experience in pharmaceutical finance and operations, with expertise in financial management, business development, and manufacturing efficiency. He serves as an executive officer at Bionpharma, a manufacturer and supplier of generic prescription drugs, over-the-counter products, and softgel capsules.
VK
Venkatachalam KrishnanExecutive
LS
Lavesh SamtaniExecutive
Board
JG
CS
Carol S. Ben-MaimonBoard director
RV
Richard Van DuyneBoard director
DW
David W. GoodmanBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$37.2M disclosed across 2 rounds · 2014–2015
▶$6.5MraisedDec 2015 · 1 investors · PharmaceuticalsRule 506(b)
▶$6.5MraisedDec 2015 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard Van DuyneDirector
- Venkatachalam KrishnanExecutive Officer, Director
- James GaleDirector
- Carol S. Ben-MaimonDirector
- David W. GoodmanDirector
- Lavesh SamtaniExecutive Officer
- Gaurav MehrotraExecutive Officer
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$30.7MraisedMay 2015 · 10 investors · PharmaceuticalsRule 506(b)
▶$30.7MraisedMay 2015 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Gaurav MehrotraExecutive Officer
- Carol S. Ben-MaimonDirector
- Richard Van DuyneDirector
- David W. GoodmanDirector
- James GaleDirector
- Venkatachalam KrishnanExecutive Officer, Director
- Lavesh SamtaniExecutive Officer
- Offering amount
- $30.7M
- Amount sold
- $30.7M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Bionpharma do?
- Bionpharma researches, develops, and manufactures generic prescription drugs and over-the-counter products, and is one of the largest US suppliers of softgel capsules. It also sells OTC products online through its A+ Health brand on Amazon.
- Who are Bionpharma's investors?
- Bionpharma's investors include Signet Healthcare Partners.
- How much funding has Bionpharma raised?
- Bionpharma has disclosed $37.2M raised across 2 rounds.
- Where is Bionpharma headquartered?
- Bionpharma is headquartered in Princeton, US.